More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

Published:2001-06 Issue:3 Volume:3 Page:315-322
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Stewart Simon¹²,MacIntyre Kate²,Hole David J.³,Capewell Simon²,McMurray John J.V.¹

Affiliation:

1. Clinical Research Initiative in Heart Failure; University of Glasgow; Glasgow G12 8QQ UK

2. Department of Public Health; University of Glasgow; Glasgow G12 8QQ UK

3. West of Scotland Cancer Surveillance Unit; University of Glasgow; Glasgow G12 8QQ UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine;Garg;J Am Coll Cardiol,1993

2. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure;Bonneux;Am J Public Health,1994

3. Our future society: a global challenge;Kelly;Circulation,1997

4. Hospitalisation of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995;Haldeman;Am Heart J,1999

5. Outcomes of acute exacerbation of severe congestive heart failure;Jaagosild;Arch Int Med,1998

Cited by 850 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Versatile whey acidic protein four-disulfide core domain proteins: biology and role in diseases;Frontiers in Cell and Developmental Biology;2024-09-04

2. The genetic association between hyperthyroidism and heart failure: a Mendelian randomization study;Frontiers in Endocrinology;2024-04-12

3. Hydrogel advancements in vascular tissue regeneration: a comprehensive review and future prospects;Emergent Materials;2024-04-07

4. Heart failure management with β-blockers: can we do better?;Current Medical Research and Opinion;2024-04

5. Stem Cell Therapy against Ischemic Heart Disease;International Journal of Molecular Sciences;2024-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3